[ Price : $8.95]
Adamas Pharmaceuticals says its Nurelin met its primary endpoint in a Phase 2/3 trial in treating levodopa-induced Dyskinesia in P...[ Price : $8.95]
Federal Register Notice: FDAs Vaccines and Related Biological Products Advisory Committee will meet 11/13 to hear an overview of r...[ Price : $8.95]
FDA approves a StemCells, Inc. IND application for clinical testing of its HuCNS-SC human neural stem cells for treating chronic s...[ Price : $8.95]
In its fifth GMP-related recall since May 1, Hospira recalls one lot of metoclopramide injection and two lots of ondansetron injec...[ Price : $8.95]
Forest Laboratories and Royalty Pharma Collection Trust jointly file a lawsuit in Delaware federal court against First Time U.S. G...[ Price : $8.95]
FDA clears a Nucletron 510(k) for Esteya, an electronic brachytherapy system for treating skin cancer.[ Price : $8.95]
Attorney Bruce Manheim raises issues companies should resolve when considering a citizen petition or lawsuit against FDA over a ge...[ Price : $8.95]
FDA tells Zogenix there will be another short delay before it issues an action letter on the companys NDA for Zohydro ER.